Figure 1.
Persistence to statin treatment after the CPK measurement or rhabomyolysis. x axis: Time in days of duration of statin treatment from the first statin prescription after the CPK measurement or rhabomyolysis. y axis: Percentage of patients continuing statin treatment at a time point. , Normal CPK;
, one to two times ULN;
, two to three times ULN;
, three to four times ULN;
, >four times ULN;
, rhabdomyolysis